GlassScriptPhysician profile
Bharat Shah
NPI 1548264179
$1,903.13
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $434 · 2021: $216 · 2022: $650.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $294.36 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $172.16 | 2019-2022 | |
| Allergan, INC. | $155.08 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $125.11 | 2020-2022 | |
| Abbvie INC. | $99.62 | 2022 | |
| Nevro Corp. | $87.21 | 2019-2022 | |
| Amgen INC. | $78.65 | 2019-2022 | |
| Assertio Therapeutics, INC. | $72.40 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $70.05 | 2022 | |
| Novartis Pharmaceuticals Corporation | $65.62 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $64.13 | 2022 | |
| Arbor Pharmaceuticals, INC. | $63.69 | 2020-2022 | |
| Pfizer INC. | $57.71 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.41 | 2019-2020 | |
| Nalu Medical, INC. | $40.34 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $39.02 | 2019 | |
| Tersera Therapeutics LLC | $37.82 | 2019 | |
| Almatica Pharma LLC | $36.24 | 2021 | |
| Medtronic, INC. | $34.43 | 2021-2022 | |
| Medtronic USA, INC. | $32.81 | 2019 | |
| Lundbeck LLC | $32.46 | 2020-2021 | |
| Fidia Pharma USA INC. | $31.69 | 2019 | |
| Supernus Pharmaceuticals, INC. | $29.55 | 2019 | |
| Vertical Pharmaceuticals, LLC | $27.82 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $26.01 | 2022 | |
| Zyla Life Sciences, INC. | $16.58 | 2019 | |
| Ibsa Pharma INC. | $14.06 | 2021 | |
| Horizon Therapeutics Plc | $12.90 | 2022 | |
| Boston Scientific Corporation | $12.44 | 2022 | |
| Redhill Biopharma INC. | $11.72 | 2021 | |
| Bioventus LLC | $11.04 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bharat Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.